Misonix Inc (MSON) Stock Price, Forecast & Analysis
USA - NASDAQ:MSON -
MSON Key Statistics, Chart & Performance
The current stock price of MSON is 26.54 null. In the past month the price increased by 4.9%. In the past year, price increased by 133.63%.
MSON Latest News, Press Relases and Analysis
MSON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.45 | 221.04B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.45 | 205.11B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.75 | 151.88B | ||
| SYK | STRYKER CORP | 27.62 | 139.05B | ||
| IDXX | IDEXX LABORATORIES INC | 56.5 | 57.00B | ||
| BDX | BECTON DICKINSON AND CO | 13.11 | 54.18B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.14 | 50.00B | ||
| RMD | RESMED INC | 25.5 | 36.84B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.99 | 33.52B | ||
| PODD | INSULET CORP | 71.4 | 22.97B | ||
| DXCM | DEXCOM INC | 31.25 | 22.80B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Related stock screener links
About MSON
Company Profile
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. The company is headquartered in Farmingdale, New York and currently employs 281 full-time employees. The firm is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.
Company Info
Misonix Inc
1938 New Hwy
Farmingdale NEW YORK 11735 US
CEO: Stavros G. Vizirgianakis
Employees: 281
Phone: 16319279113.0
Misonix Inc / MSON FAQ
Can you describe the business of Misonix Inc?
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. The company is headquartered in Farmingdale, New York and currently employs 281 full-time employees. The firm is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.
What is the current price of MSON stock?
The current stock price of MSON is 26.54 null. The price increased by 4.74% in the last trading session.
What is the dividend status of Misonix Inc?
MSON does not pay a dividend.
What is the ChartMill technical and fundamental rating of MSON stock?
MSON has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the Price/Earnings (PE) ratio of Misonix Inc (MSON)?
Misonix Inc (MSON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.84).
Can you provide the market cap for Misonix Inc?
Misonix Inc (MSON) has a market capitalization of 462.06M null. This makes MSON a Small Cap stock.
When does Misonix Inc (MSON) report earnings?
Misonix Inc (MSON) will report earnings on 2022-02-11, after the market close.
MSON Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MSON. When comparing the yearly performance of all stocks, MSON is one of the better performing stocks in the market, outperforming 90.14% of all stocks.
MSON Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MSON. While MSON seems to be doing ok healthwise, there are quite some concerns on its profitability.
MSON Financial Highlights
Over the last trailing twelve months MSON reported a non-GAAP Earnings per Share(EPS) of -0.84. The EPS increased by 16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -19.55% | ||
| ROA | -7.28% | ||
| ROE | N/A | ||
| Debt/Equity | 0.29 |
MSON Forecast & Estimates
3 analysts have analysed MSON and the average price target is 28.56 null. This implies a price increase of 7.61% is expected in the next year compared to the current price of 26.54.
For the next year, analysts expect an EPS growth of 10.14% and a revenue growth 16.14% for MSON